These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19287070)

  • 1. The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas.
    Bolander A; Agnarsdóttir M; Strömberg S; Ponten F; Hesselius P; Uhlen M; Bergqvist M
    Cancer Genomics Proteomics; 2008; 5(6):293-300. PubMed ID: 19287070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of galectin-3 expression with melanoma progression and prognosis.
    Brown ER; Doig T; Anderson N; Brenn T; Doherty V; Xu Y; Bartlett JM; Smyth JF; Melton DW
    Eur J Cancer; 2012 Apr; 48(6):865-74. PubMed ID: 22071132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
    Prieto VG; Mourad-Zeidan AA; Melnikova V; Johnson MM; Lopez A; Diwan AH; Lazar AJ; Shen SS; Zhang PS; Reed JA; Gershenwald JE; Raz A; Bar-Eli M
    Clin Cancer Res; 2006 Nov; 12(22):6709-15. PubMed ID: 17121890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma.
    Strömberg S; Agnarsdóttir M; Magnusson K; Rexhepaj E; Bolander A; Lundberg E; Asplund A; Ryan D; Rafferty M; Gallagher WM; Uhlen M; Bergqvist M; Ponten F
    J Proteome Res; 2009 Apr; 8(4):1639-46. PubMed ID: 19714869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of galectin-3 in primary cutaneous melanoma.
    Buljan M; Šitum M; Tomas D; Milošević M; Krušlin B
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1174-81. PubMed ID: 21175876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
    Abdou AG; Hammam MA; Farargy SE; Farag AG; El Shafey EN; Farouk S; Elnaidany NF
    Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
    Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podoplanin expression in cancer-associated fibroblasts predicts aggressive behavior in melanoma.
    Kan S; Konishi E; Arita T; Ikemoto C; Takenaka H; Yanagisawa A; Katoh N; Asai J
    J Cutan Pathol; 2014 Jul; 41(7):561-7. PubMed ID: 24588302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX10 expression in superficial spreading and nodular malignant melanomas.
    Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
    Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
    Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
    Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
    Nambiar S; Mirmohammadsadegh A; Hassan M; Mota R; Marini A; Alaoui A; Tannapfel A; Hegemann JH; Hengge UR
    Carcinogenesis; 2007 Dec; 28(12):2501-10. PubMed ID: 17768177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
    Flørenes VA; Maelandsmo GM; Faye R; Nesland JM; Holm R
    J Pathol; 2001 Dec; 195(5):530-6. PubMed ID: 11745687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
    Hazan C; Melzer K; Panageas KS; Li E; Kamino H; Kopf A; Cordon-Cardo C; Osman I; Polsky D
    Cancer; 2002 Aug; 95(3):634-40. PubMed ID: 12209757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT 1 expression in nevi and melanomas: a marker of melanocytic invasion into the dermis.
    Garrido-Ruiz MC; Rodriguez-Pinilla SM; Pérez-Gómez B; Rodriguez-Peralto JL
    J Cutan Pathol; 2010 May; 37(5):542-8. PubMed ID: 19638168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases.
    Orlow SJ; Silvers WK; Zhou BK; Mintz B
    Cancer Res; 1998 Apr; 58(7):1521-3. PubMed ID: 9537258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of human angiotropic primary melanoma: selection of 15 differentially expressed genes potentially involved in extravascular migratory metastasis.
    Lugassy C; Lazar V; Dessen P; van den Oord JJ; Winnepenninckx V; Spatz A; Bagot M; Bensussan A; Janin A; Eggermont AM; Barnhill RL
    Eur J Cancer; 2011 May; 47(8):1267-75. PubMed ID: 21334873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
    Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
    J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.